Stemline Therapeutics Inc (NASDAQ:STML)

15.19
Delayed Data
As of Feb 27
 -1.01 / -6.23%
Today’s Change
10.50
Today|||52-Week Range
29.50
-10.96%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale5/21/201415,250$13.32$203.1K+14.38%
Bergstein Ivan
Chief Executive Officer
Sale11/26/201411,974$14.40$172.4K+2.70%
Rowinsky Eric K
Chief Medical Officer
Sale4/25/201410,879$15.01$163.3K+2.29%
Gionco David G
Chief Accounting Officer
Sale1/20/20153,311$14.22$47.1K+6.45%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K+7.88%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K+7.88%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K+7.88%
Bergstein Ivan
Chief Executive Officer
Buy9/03/20142,000$11.05$22.1K+39.10%
Hoberman Kenneth
Chief Operating Officer
Buy9/02/20142,000$10.99$22.0K+38.72%
Zuerblis Kenneth J
Director
Buy9/02/20141,000$11.14$11.1K+38.72%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account